As of today, there are no drugs that can cure Alzheimer’s disease: every 65 seconds someone in the US develops the disease. Alzheimer’s disease, is now the second leading cause of death in Australians.
Take a look at the current innovation landscape of drugs for Alzheimer’s disease, and find out who is most likely to take the lead of this billion-dollar market.
What you will learn in this webinar:
- The global IP landscape of technologies related to treating and diagnosing Alzheimer’s
- How to use legal status information to evaluate the current value of Alzheimer’s-related IP
- The importance of ownership data for identifying the strongest patent portfolios
- Use of smart analytics vs. patent activity statistics
Provide actionable insights to support strategic decision-making
Effectively communicate the value of your IP with powerful insights and visualizations, enabling you to turn your patent department into a strategic consulting unit.
Taking patent analytics out of the ‘black box’
With LexisNexis® Intellectual Property Solutions, you benefit from a highly transparent scientific approach to patent data analysis. Forget opaque algorithms and analytics ‘black boxes’, we can show you exactly how we reached at our insights. Patent analytics solution, LexisNexis® PatentSight®, is built on the foundation of ground-breaking validated research, which is often cited in leading scientific publications.
Brought together in the patent value indicator, the Patent Asset Index™, this objective approach to assessing patent quality and benchmarking patent portfolios has become a de facto standard in measuring portfolio strength.
High-quality data: a prerequisite for reliable patent analysis
LexisNexis Intellectual Property Solutions validates and quality-assures patent data by assigning patents to their accurate commercial owners and verifying their legal validity and remaining lifetime.
Superior datasets allow you to unveil valuable patent insights and see clearly who wields commercial power over the inventions that underpin promising patents.
Patent analyses conducted with PatentSight® have proven to be more reliable than analyses based on unprocessed patent data.